We may earn a commission when readers sign up through partner links. Rankings reflect our published methodology, not advertiser fees.
GLP·Agonists See Editor's Pick

Medication

Mounjaro

Mounjaro is brand-name tirzepatide, a dual GIP/GLP-1 receptor agonist approved for Type 2 diabetes. Tirzepatide produced the largest weight-loss effect sizes recorded in modern incretin trials. List price approximately $1,069/month.

Generic name: tirzepatide · Manufacturer: Eli Lilly · Updated May 2026

FDA status
FDA-approved 2022
List price
$1069/month
Schedule
Once weekly
Form
Subcutaneous injection (prefilled single-dose pen)

Quick facts

Generic nametirzepatide
Brand manufacturerEli Lilly
FDA indicationType 2 diabetes (off-label use for weight loss is common)
FDA approval year2022
FormSubcutaneous injection (prefilled single-dose pen)
ScheduleOnce weekly
List price (cash)$1069/month

Available doses

What it's used for

How Mounjaro compares

For drug-class comparisons, see our medication-comparison hub:

Semaglutide vs Tirzepatide Ozempic vs Wegovy Mounjaro vs Zepbound Wegovy vs Zepbound Compounded vs Brand

Compounded alternatives

Compounded tirzepatide is available through telehealth at $249–$499/month. Compounded products are not FDA-approved as finished drugs and are prepared by licensed compounding pharmacies on a per-patient basis. April 2026 FDA guidance applies to compounded GLP-1 advertising and prescribing. See our compounded vs brand-name guide for details.

Reputable telehealth options for compounded tirzepatide:

Insurance coverage

Coverage varies significantly by carrier and employer plan. See our insurance hub for plan-specific guidance:

UnitedHealthcare Anthem BCBS Aetna Cigna Medicare Part D TRICARE

Frequently asked questions

What is Mounjaro?

Mounjaro is the brand name for tirzepatide, manufactured by Eli Lilly. Mounjaro is brand-name tirzepatide, a dual GIP/GLP-1 receptor agonist approved for Type 2 diabetes. Tirzepatide produced the largest weight-loss effect sizes recorded in modern incretin trials. List p

How much does Mounjaro cost?

Mounjaro list price is approximately $1069/month. Insurance may cover it with prior authorization for FDA-approved indications. Compounded tirzepatide is available at $249–$499/month.

Is Mounjaro FDA-approved?

FDA-approved 2022. Indication: Type 2 diabetes (off-label use for weight loss is common).

What are the dosing steps for Mounjaro?

Doses available: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg. Schedule: Once weekly. Always follow your prescribing clinician's titration plan.

What's the difference between Mounjaro and other GLP-1s?

See our medication comparisons hub for head-to-head pages on Wegovy vs Zepbound, Ozempic vs Wegovy, and semaglutide vs tirzepatide.

Note: This page is an editorial overview, not medical advice. Always consult a licensed clinician about whether Mounjaro is appropriate for you.